Biohacker Bryan Johnson’s Rs 170 crore anti-aging experiment failed, revealing that he mistakenly aged himself

Tech entrepreneur Bryan Johnson is now an outstanding figure in the modern movement with a focus on achieving immortality. Johnson, who spends $2 million (about Rs 17 crore) a year to reverse the aging process, is known for his use of advanced health technology. He adopted procedures such as blood transfusion and whole plasma exchange of his son, which attracted great attention.

In a recent revelation, Bryan Johnson, 46, may have found an unexpected result, and his efforts to slow down aging may have inadvertently accelerated it.

In a new video posted on his YouTube channel, Johnson revealed a major mistake about rapamycin, a drug he believes is crucial to his health plan. Originally used in organ transplant patients, this immunosuppressant is now prevalent in the anti-aging circle, and Johnson has been testing it for five years.

According to a 2009 study, rapamycin may increase the lifespan of mice by 14%, while 65% of participants in the 2023 human trial reported improved health while taking the drug, Johnson carefully modified his dose to manage potential benefits and risks. But instead of experiencing the revival, tech entrepreneurs began to notice attention about side effects.

Johnson experienced several adverse reactions, including oral ulcers, slow wound healing, cholesterol imbalance and increased blood sugar levels. But what really cares about him is his increased resting heart rate, a key indicator of sleep and recovery. The gap between expectations and what actually happened has led to a serious reassessment.

A recent Yale University study has intensified attention, which challenges the positive view of rapamycin. The researchers found that the drug actually accelerates biological aging in 16 epigenetic markers. For Johnson, at least, it may have been speeding up the aging process rather than maintaining youth.

Faced with the result he spent millions of people avoiding, Johnson chose transparency over embarrassment. “I’ll smile with you for those who are laughing at home,” he said with a smile, and since then, he has stopped taking medicine.

But this is not a resignation – it is a reset. Johnson remains committed to experimenting, recording and vital sharing. “It’s important to talk about success and failure,” he said. “That’s how all of us learn.”

Bryan Johnson’s self-funded mission is to open experiments on the border of longevity, as well as associated high-risk risks. While some see him as a visionary, others are skeptical of his approach. Regardless of your point of view, it is obvious: In the struggle with aging, even the most carefully planned actions may speed up the process.